Basic Information
OCULGEN Focuses on Innovative Macromolecular Ophthalmic Drugs for Fundus Diseases
--
Guangdong,China
15~50 people
August 24, 2022
--
cck@oculgen.com.cn
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios